---

Complete Guide to AV Fistula Cannulation

From Absolute Basics to Advanced Clinical Practice

---

PART 1 — FOUNDATIONS: WHAT IS AN AV FISTULA AND WHY DO WE CANNULATE IT?

1.1 What Is an AV Fistula? (Layman Start)

• Enlarges in diameter
• Thickens its walls
• Develops a strong pulsatile blood flow
• Becomes easily palpable and visible

---

1.2 Basic Anatomy of an AV Fistula

---

1.3 Why Two Needles?

1. Removing blood from the patient → sending it to the dialysis machine
2. Returning cleaned blood back to the patient

Naming convention note: Despite being called "arterial" and "venous" needles, both are physically inserted into the fistula vein. The names reflect function, not anatomy. The "arterial" needle is the one connected to the arterial (blood-out) line; the "venous" needle is connected to the venous (blood-return) line.

---

PART 2 — THE NEEDLES: HARDWARE BASICS

2.1 Fistula Needle Anatomy

• Metal cannula: Typically 15G or 16G (gauge), 25 mm or 35 mm length. Larger gauge = smaller number = bigger hole. Most common is 15G for routine dialysis.
• Wings (butterfly wings): Plastic tabs on either side for gripping during insertion and taping after
• Short tubing segment: Connects to the blood line
• Bevel: The angled, sharp tip of the needle

Gauge selection:

---

2.2 The Bevel

• Bevel up: The opening faces upward (toward the skin surface). Easier to insert, lower risk of posterior wall puncture, most commonly used.
• Bevel down: The opening faces the vessel wall. Used by some experienced cannulators in specific situations — e.g., when a fistula has a thin anterior wall and risk of blowout, bevel-down provides better flow against a thick posterior wall.

---

PART 3 — PRE-CANNULATION ASSESSMENT (The Steps Before the Needle Touches Skin)

3.1 Assessment Protocol

Visual Inspection:

• Look for hematomas, bruising, skin breakdown, infection signs (redness, warmth, swelling, discharge)
• Look for aneurysms (bulging segments) — note their location
• Look for previous needle sites — identify healing punctures
• Check for skin integrity over proposed cannulation sites

Palpation:

• Feel the thrill along the entire fistula body — it should be a continuous, soft buzzing sensation
• A strong, pulsatile thump without thrill can indicate outflow stenosis
• Loss of thrill → suspect thrombosis → do NOT cannulate without further assessment
• Map the course of the vein from anastomosis to outflow

Auscultation:

• Use a stethoscope over the fistula
• A normal bruit is low-pitched, continuous (both systolic and diastolic)
• A high-pitched, only systolic bruit suggests stenosis
• No bruit → suspect clot

Patient Interview:

• "How was your last session?" — any problems getting needles in? Any alarms?
• "Any pain, swelling, or changes since last time?"
• Check last session's documentation for needle sites used, pressures, any issues

---

3.2 Fistula Maturation Check (New Fistulas)

• Blood flow through the fistula ≥ 600 mL/min (measured by Doppler ultrasound)
• Straight, well-defined vein segment
• Supports cannulation with two 15-16G needles without significant difficulty

---

PART 4 — CANNULATION TECHNIQUES

4.1 The Three Cannulation Techniques

1. Rope Ladder (Step Ladder) Technique

• The entire fistula length is divided into multiple potential sites
• Each session, the arterial and venous needles are placed at new sites, moving progressively along the vessel
• After using all sites (typically 10–15 sessions), you cycle back to the beginning (sites have healed by then)

• Even distribution of trauma along the vessel wall
• Prevents focal aneurysm formation
• Preserves long-term fistula integrity
• Considered the preferred technique by most guidelines for long-term fistula preservation

• Requires careful documentation of previous sites
• Some sites may be anatomically more difficult
• Patient experiences variable discomfort depending on site

---

2. Buttonhole (Constant-Site) Technique

• Phase 1 (Track creation, sessions 1–6 approximately): Only the most skilled cannulator uses sharp needles at the exact same site, angle, and depth each time. This requires precision — even 1–2 mm deviation destroys track formation.
• Phase 2 (Track established): Once the fibrous tunnel is formed (typically after 6–12 sessions with sharp needles), a blunt cannula (blunt buttonhole needle) is used. The blunt needle follows the track like a key in a lock — it doesn't cut, it slides.

• Significantly reduced pain (patient inserts own needle after track established — many patients self-cannulate using buttonhole)
• Reduced hematoma formation
• No missed sticks if track is well established
• Particularly beneficial for patients with poor pain tolerance or needle anxiety

• High infection risk — the scab at the buttonhole site must be removed before each cannulation (scab harbors bacteria); improper technique → bacteremia → endocarditis risk
• Requires extraordinary consistency — only one or two designated cannulators should create the track
• If a session is missed or a different cannulator deviates, track may be lost
• Not suitable for AV grafts made of synthetic PTFE (as confirmed in the Vascular Access text) — the synthetic material does not form a biological tunnel the way a native vein does
• Suitable for native AVF and biologic grafts (e.g., bovine ureter)

1. Remove scab completely (soaked with antiseptic or mechanically)
2. Clean site for minimum 30 seconds with chlorhexidine or povidone-iodine
3. Let dry completely before inserting needle
4. Apply mupirocin to the site post-dialysis (many centers)

---

3. Area (General Area) Cannulation — The BAD Technique

• Focal aneurysm formation (ballooning of the vein wall)
• Vessel wall thinning and pseudoaneurysm
• Risk of rupture
• Stenosis at chronically traumatized segments

---

4.2 Cannulation Steps: Step-by-Step Procedural Detail

Equipment preparation:

• Two fistula needles (15G or 16G, appropriate length)
• Sterile gloves
• Antiseptic (chlorhexidine 2% or povidone-iodine 10%)
• Sterile gauze
• Tape / transparent dressing
• Normal saline (NS) flush syringe (3–5 mL)
• Tourniquet (if needed for difficult access — used sparingly)
• Tourniquet is optional and controversial — discussed below

Step 1: Hand hygiene and glove

Step 2: Clean the site

Step 3: Assess and mark sites

Step 4: Prepare the needle

Step 5: Tension the skin

Step 6: Insert the needle

• Bevel up (standard)
• Angle of insertion: 25–35 degrees for superficial fistulas; 45 degrees for deep-seated fistulas. As you enter the vein and get a flashback, reduce the angle to 10–15 degrees to advance the needle along the vein lumen without puncturing the posterior wall.
• Insert with steady, controlled pressure — not a jab, not a tentative poke

Step 7: Confirm placement

• Flashback of blood into the needle hub/tubing = successful venipuncture
• The flashback should be immediate and brisk in a well-functioning fistula
• Advance the needle another 5–15 mm along the vein lumen (bevel and shaft should be completely inside the vessel)

Step 8: Secure the needle

• Lower the angle to near-flat with the skin
• Secure with tape in a "chevron" or "H" pattern
• Wings should be taped flat — a poorly secured needle moves during dialysis and can infiltrate

Step 9: Connect lines and commence dialysis

• Connect arterial and venous blood lines
• Begin blood pump at slow speed (100–150 mL/min) initially, then ramp up to prescribed BFR

---

PART 5 — THE NS IN THE NEEDLE QUESTION (Why Some Do, Some Don't)

5.1 What Does "NS in the Needle" Mean?

5.2 Arguments FOR Pre-Flushing with NS

1. Air elimination

2. Visualizing flashback

3. Reducing clot in the needle tip

4. Lubrication during slow cannulation (see "slow cannulation" section)

5.3 Arguments AGAINST Pre-Flushing / Inserting Dry

1. Dilution of the pre-primed heparin

2. Confirmed flashback in dry needle

3. Fluid load concern (minor)

5.4 Clinical Verdict

• Difficult/deep fistulas where flashback confirmation is important
• New cannulators learning — the NS flash is an excellent teaching confirmation tool
• Slow/careful cannulation technique
• Areas where air risk is taken seriously

---

PART 6 — NEEDLE DIRECTION: ANTEGRADE VS. RETROGRADE

6.1 Definitions

• Antegrade: The needle tip points toward the heart (in the direction of normal blood flow). This is also called with the flow.
• Retrograde: The needle tip points away from the heart (against the direction of normal blood flow), toward the anastomosis.

• An antegrade arterial needle points toward the heart
• A retrograde arterial needle points toward the anastomosis (downward in the arm if the fistula is in the forearm)

6.2 Standard Configuration (The Classic Setup)

• Arterial needle: Retrograde (pointing toward anastomosis — against flow) — because you are drawing blood OUT, and the arterial needle placed retrograde actually opposes the flow, making it draw from the high-pressure anastomotic zone. This gives a stable, high-flow blood supply.
• Venous needle: Antegrade (pointing toward heart — with flow) — because you are returning blood, and pushing it in the direction it naturally flows toward the heart.

---

6.3 Configuration Comparison Table

---

6.4 Recirculation — The Key Concept

What causes recirculation?

1. Needles too close together — most common cause
2. Both needles antegrade on the same short segment — returned blood from venous needle flows backward into the arterial needle
3. Low fistula flow (fistula flow < blood pump speed) — the machine is trying to pull more blood than the fistula can supply; it recirculates
4. Reversed needle connections (arterial blood line connected to venous needle and vice versa)
5. Stenosis in the outflow vein — creates a pressure dam, forcing returned blood to recirculate

---

6.5 Detailed Analysis: All Needle Direction Scenarios

Scenario A: Arterial Retrograde + Venous Antegrade (Different segments)

• Arterial needle draws blood from the high-flow anastomotic zone
• Venous needle returns blood toward the heart, far from the arterial needle
• Blood travels: Anastomosis → (arterial needle draws here) → blood goes to machine → returns via venous needle → flows toward heart
• Recirculation: Minimal (< 5%)
• BFR support: Excellent — the retrograde arterial needle has a steady, high-pressure feed from the anastomosis
• Patient comfort: Good
• Best for: Forearm radiocephalic fistulas, upper arm brachiocephalic fistulas

Scenario B: Both Needles Antegrade, Well Separated (≥ 5–6 cm apart)

• Arterial needle points toward heart but is placed proximal (closer to anastomosis); it still draws from the high-flow zone
• Venous needle is placed distal (further up the arm) and also points toward heart
• As long as separation is adequate, returned blood from the venous needle travels forward toward the heart before any can reach the arterial needle
• Recirculation: Low (5–10%) if separation is good
• Advantage: Both needles insert "with the flow" of the vein — some cannulators find this easier anatomically and it may be more comfortable for the patient on insertion
• Important caveat: The arterial needle antegrade may experience slightly higher negative pressures at the same BFR compared to retrograde, because it is working somewhat against the natural pressure gradient

Scenario C: Both Needles Antegrade, Short Segment / Same Segment (< 3–4 cm apart)

• Returned blood from the venous needle immediately re-enters the arterial needle
• The short segment between the two needles becomes a closed recirculation loop
• Recirculation can be 20–40% or higher
• Dialysis adequacy severely compromised — Kt/V may drop 0.2–0.4 points
• Patient appears to be getting dialyzed (blood is moving at the prescribed BFR) but actual clearance of uremic toxins is poor
• Avoid whenever possible

Scenario D: Both Needles Retrograde

• Arterial needle retrograde = draws blood well (facing anastomosis, high flow)
• Venous needle retrograde = returns blood TOWARD the anastomosis, against the natural flow
• Returned blood pushes back toward the anastomosis — may force blood backward through the anastomosis, reducing effective delivery to the patient
• Creates significant recirculation
• Recirculation: Moderate to high
• Additionally: Returning blood against the normal flow direction creates turbulence and higher venous pressures on the machine
• Avoid

Scenario E: Different Veins / Segments Entirely (e.g., one in the cephalic, one in a collateral)

• Recirculation depends entirely on whether these veins share a common segment and how blood flows between them
• If the veins are completely separate (no common drainage point between needles), recirculation is near zero
• If they share outflow, recirculation depends on relative flows
• This scenario occurs in fistulas with duplicated veins or significant collaterals
• Doppler ultrasound mapping is essential to understand the anatomy before making this judgment

---

6.6 Summary: The Practical Takeaway on Direction

1. Ideal: Arterial retrograde, venous antegrade, ≥ 5 cm apart
2. Acceptable: Both antegrade if ≥ 5–6 cm separation on a long fistula segment
3. Dangerous: Both needles < 3 cm apart, regardless of direction
4. Worst: Both retrograde, or both antegrade on a short segment
5. The separation distance matters more than the direction in many real-world situations — a well-separated both-antegrade setup beats a poorly separated classic retrograde/antegrade setup every time

---

PART 7 — STARTING A NEW FISTULA: THE MOST CRITICAL PERIOD

7.1 Why New Fistulas Are So Vulnerable

• Thin, immature walls — the arterialisation process is incomplete
• Fragile neointima — the inner lining hasn't fully thickened
• No established scar tissue at needle sites to resist infiltration
• Variable, not fully predictable course — the vein may not be perfectly straight
• Potential for spasm — the newly arterialized vein can spasm, especially with pain

7.2 Criteria Before First Cannulation

• Minimum 4–6 weeks post-surgery (many experienced centers wait 8–12 weeks)
• Doppler ultrasound confirming diameter ≥ 6 mm and flow ≥ 600 mL/min
• Vein clearly visible and palpable
• Skin healing complete over the fistula segment
• Surgeon clearance

7.3 First Cannulation Protocol

Personnel:

• The most experienced cannulator available should perform the first several cannulations
• Never assign a new fistula to a student or new employee
• Some centers have a designated "fistula nurse" or fistula specialist for all new cannulations

Needle selection:

• Start with 17G (smaller = less traumatic) for the first 2–3 sessions
• Progress to 16G for sessions 4–8
• Progress to 15G only when the fistula is clearly robust and tolerating the treatment well

BFR for new fistulas:

• Session 1–3: 200–220 mL/min maximum
• Sessions 4–8: 220–250 mL/min
• Sessions 9–12: 250–280 mL/min
• After full maturation: Prescribe target BFR per standard protocol

Tourniquet use in new fistulas:

• A tourniquet (or blood pressure cuff inflated to 40–60 mmHg) proximal to the cannulation site can help engorge the vein, making it more visible and easier to cannulate
• Use with caution and release immediately after successful cannulation
• Prolonged tourniquet use on a new fistula can cause excessive pressure and wall trauma

The "one stick" rule for new fistulas:

---

7.4 Slow Cannulation vs. "Flash" Insertion — Detailed Comparison

The Flash Method:

• Experienced cannulators
• Well-matured, superficial, easily palpable fistulas
• Rope-ladder or established sites
• High-flow fistulas where flashback is instant

• Less time the needle is moving = less chance of "sawing" the vessel wall
• Often less painful — a quick, clean insertion is less painful than a slow, tentative one
• Efficient in high-volume units

The Slow / Controlled Method:

• New cannulators learning
• Deep fistulas (> 6 mm below skin)
• Fistulas with poor visualization (obese patients, scarred access)
• New fistulas on first cannulations
• Buttonhole track establishment

• Better control of depth — reduces risk of posterior wall puncture
• The NS pressure test gives tactile feedback that flash alone doesn't
• Better for difficult/uncertain access

• More movement of the needle through tissue = more trauma if multiple adjustments
• Can be more painful if the slow movement stimulates more pain receptors over a longer time
• In a deep vein, a slow entry may miss the optimal angle

Practical nuance on pain:

• Pre-application of topical anesthetic cream (EMLA — lidocaine/prilocaine) 30–60 minutes before dialysis markedly reduces insertion pain and allows the cannulator to work more slowly and carefully if needed
• Intradermal lidocaine (0.1–0.2 mL of 1% lidocaine with a tiny 27G–30G needle) immediately before insertion is used in some centers

---

PART 8 — BLOOD FLOW RATE (BFR) AND DIALYSATE FLOW RATE (DFR): DETAILED ANALYSIS

8.1 What Determines How Much Dialysis a Patient Gets?

• K = dialyzer clearance of urea (mL/min) — how efficiently the dialyzer removes urea
• t = time on dialysis (minutes)
• V = volume of distribution of urea (approximately total body water, ~60% of body weight in liters)

1. Blood flow rate (BFR) — how much blood passes through the dialyzer per minute
2. Dialysate flow rate (DFR) — how much fresh dialysate passes through the dialyzer per minute
3. Dialyzer characteristics (surface area, membrane type, KoA)
4. Treatment time
5. Recirculation (higher recirculation → lower effective clearance)

---

8.2 Blood Flow Rate (BFR): What Happens at Each Level?

The physics:

---

BFR 200 mL/min

• New fistulas (first sessions)
• Fragile access with frequent arterial pressure alarms
• Patients who cannot tolerate higher flows (hemodynamically unstable)
• Emergency dialysis for hyperkalemia where urgent access is whatever is available

• Kt/V significantly lower than at higher flows
• For a 4-hour session with a standard dialyzer: Kt/V approximately 0.9–1.1 (below target for many patients unless treatment time is extended)
• Urea clearance is substantially reduced
• Adequate for acute situations or short-term use, but not for routine thrice-weekly maintenance hemodialysis in most patients

• Arterial (pre-pump) pressure: Less negative (e.g., -60 to -120 mmHg)
• Venous (post-pump) pressure: Lower (e.g., 80–140 mmHg)
• Minimal trauma to fistula needle sites

---

BFR 240 mL/min

• Early new fistulas (weeks 2–6 of use)
• 16G needles
• Patients with borderline access flow or recurrent arterial alarms at higher flows
• Supplemental to longer treatment times

• Kt/V approximately 1.1–1.25 for 4-hour session with standard dialyzer
• Borderline adequate — typically sufficient only if treatment time is at least 4 hours and dialyzer is high-efficiency
• Better than 200, but still below what most patients need

• Arterial pressure: -80 to -150 mmHg
• Better fistula wall stress than 200 mL/min? No meaningful difference in practice

---

BFR 280 mL/min

• Maturing fistulas (weeks 8–16)
• Patients with 16G needles or marginal access
• Dialyzers with high KoA (clearance efficiency)

• Kt/V approximately 1.2–1.35 for 4-hour session
• Adequate for most patients if dialyzer KoA is high (>700) and DFR is ≥ 500 mL/min
• The "floor" of reasonable maintenance dialysis with standard parameters

• Arterial pressure: -100 to -175 mmHg
• Venous pressure: 120–160 mmHg
• Within acceptable range for most access types

---

BFR 300 mL/min

• Suitable for most mature fistulas, many AV grafts
• Works well with 15G or 16G needles
• Appropriate across most patient sizes

• Kt/V approximately 1.3–1.45 for 4-hour session with standard dialyzer and DFR 500–600 mL/min
• Reaches minimum adequacy targets for most patients
• Reliable, safe, well-supported BFR across all access types

---

BFR 350 mL/min

• Best suited to mature brachiocephalic or basilic vein transposition fistulas
• 15G needles required
• Good fistula diameter (≥ 8 mm) needed

• Kt/V approximately 1.5–1.65 for 4-hour session
• Above target — provides a margin for recirculation or access issues

---

BFR 400 mL/min and above

• High-efficiency dialysis (HDF — hemodiafiltration)
• Large body mass patients needing high Kt/V
• Extended treatment times combined with high BFR
• Needs 14G–15G needles, very mature high-flow fistula

• Kt/V > 1.6 possible, contributing to better long-term outcomes when combined with extended time
• But: higher BFR beyond ~400 mL/min offers diminishing returns on urea clearance because the bottleneck shifts to the dialyzer membrane and dialysate saturation, not blood delivery

• Arterial pressure can go to -200 mmHg or lower — significant negative pressure
• If the fistula cannot sustain these flows, the vessel collapses around the needle tip → arterial pressure alarms → machine stops/slows → effective BFR is lower than prescribed
• High venous return pressures can cause bruising at the venous site

---

8.3 BFR Comparison Summary Table

---

8.4 Dialysate Flow Rate (DFR): What Happens at Each Level?

The physics:

---

DFR 300 mL/min

• Rarely in modern practice for routine hemodialysis
• Sometimes used in home dialysis machines or portable/wearable dialysis devices
• Emergency or provisional dialysis situations

• At BFR 200–240 mL/min: DFR 300 is minimally limiting (ratio is adequate)
• At BFR 300 mL/min: DFR 300 = 1:1 ratio → dialysate saturates in the mid-to-distal dialyzer → clearance efficiency drops by approximately 10–15% compared to DFR 500
• Kt/V reduction compared to DFR 500: approximately 0.1–0.2 units
• Not recommended for routine maintenance dialysis at standard BFR

---

DFR 400 mL/min

• Older dialysis machines with limited DFR options
• Patients on extended dialysis where dialysate volume is a concern (home dialysis)
• Low-flux dialysis protocols

• Kt/V approximately 0.1 lower

• For a patient with a small body water volume (small patient, low V), DFR 400 may still achieve Kt/V ≥ 1.4
• For a large patient, it may be inadequate

---

DFR 500 mL/min

• Historically, the ratio 500:300 (DFR:BFR) was found to provide adequate clearance without wasteful over-flow
• Water treatment systems in most dialysis centers are designed to produce dialysate at 500 mL/min per machine efficiently
• Studies through the 1980s–2000s established 500 mL/min as the benchmark

• At BFR 300 mL/min: DFR:BFR ratio = 1.67:1 → optimal, no significant saturation
• At BFR 400 mL/min: DFR:BFR ratio = 1.25:1 → mild saturation in distal dialyzer
• This is the sweet spot for most conventional HD: BFR 300–350 with DFR 500

---

DFR 550 mL/min

• Modern machines can be set to 550 with 10 mL/min increments
• Useful when stepping up from 500 but not yet needing full 600
• Clinical difference from 500 is modest: approximately 3–5% improvement in clearance

---

DFR 600 mL/min

• At BFR 300 mL/min: Increasing DFR from 500 → 600 provides < 5% improvement in urea clearance — clinically marginal
• At BFR 400 mL/min: Increasing DFR from 500 → 600 provides approximately 6–10% improvement — clinically relevant
• At BFR 400–500 mL/min with high-efficiency dialyzer (KoA > 1000): DFR 600–800 mL/min provides 10–15% improvement in clearance — clinically significant

• High-efficiency dialysis (BFR ≥ 350–400 mL/min)
• Large patients where higher Kt/V targets are hard to reach
• Online HDF (hemodiafiltration) — where DFR is even higher (600–800 mL/min) to generate substitution fluid
• Patients with residual renal function who need to maintain it — higher efficiency allows shorter sessions, potentially preserving residual function better

• Higher water consumption (dialysate is discarded)
• More demand on the reverse osmosis water treatment system
• Higher consumable cost
• Negligible clinical benefit at BFR < 350 mL/min

---

8.5 DFR vs. BFR Interaction Table

---

8.6 The Harrison's Perspective

---

PART 9 — PART A AND PART B OF THE FISTULA NEEDLE/CIRCUIT

9.1 What is "Part A" and "Part B"?

Part A — The Arterial Limb (Blood Out)

1. Arterial needle (physically in the fistula, drawing blood out)
2. Arterial blood line (tubing from the needle to the pump segment)
3. Pre-pump arterial segment (between needle and blood pump — this is where negative pressure develops)
4. Blood pump (peristaltic pump — the engine driving blood through the circuit)
5. Heparin infusion port (on the arterial line, just after the pump — where systemic anticoagulation is delivered)
6. Pre-dialyzer segment (blood line going into the dialyzer)
7. Pressure monitoring port (arterial pressure monitor — measures pre-pump and/or post-pump pressures)

• Creates the negative pressure that draws blood from the fistula
• Pumps blood toward the dialyzer
• Delivers anticoagulant (heparin or citrate) to prevent clotting in the circuit
• The arterial pressure (AP) monitor reflects the ease or difficulty of blood withdrawal from the access

• Pre-pump: -50 to -250 mmHg (negative — suction)
• The more negative it is at a given BFR, the harder the pump is working to pull blood → suggests poor blood supply (poor access flow, needle position problem, stenosis)

---

Part B — The Venous Limb (Blood Return)

1. Post-dialyzer segment (blood line exiting the dialyzer)
2. Drip chamber / bubble trap (catches air bubbles — critical safety component)
3. Air detector (ultrasonic detector on the bubble trap — halts the pump if air is detected)
4. Venous pressure monitor (measures pressure in the return limb)
5. Venous blood line (tubing from bubble trap to venous needle)
6. Venous needle (physically in the fistula, returning blood)

• Returns cleaned blood to the patient
• The bubble trap catches air that might have entered the circuit
• The venous pressure monitor detects resistance in the return path — elevated VP can indicate:
  • Venous needle clot
  • Venous needle against vessel wall
  • Outflow stenosis in the fistula
  • Line clamp accidentally left on

• 80–200 mmHg (positive — pushing blood into the access)
• Elevated VP (> 200–250 mmHg): suspect venous needle problem or outflow stenosis
• Very low VP (< 50 mmHg): suspect disconnection or very large-bore access

---

9.2 Pressure Alarms and What They Mean

---

PART 10 — PATIENT COMFORT: A COMPREHENSIVE APPROACH

10.1 Pain Mechanisms in Cannulation

1. Skin/dermal pain — the most significant; dermis is richly innervated
2. Subcutaneous tissue pain — less sensitive
3. Vessel wall pain — the vessel adventitia (outer layer) has some nerve supply; the intima (inner lining) has very little
4. Procedural anxiety/anticipatory pain — significant in many dialysis patients; psychological component amplifies perceived pain

---

10.2 Pain Management Strategies

Topical Anesthetics

• EMLA cream (lidocaine 2.5% + prilocaine 2.5%): Apply under occlusive dressing 60–90 minutes before dialysis. Highly effective — reduces cannulation pain by 50–70%. Requires patient compliance (applying cream before leaving home).
• LMX4 cream (4% liposomal lidocaine): Similar efficacy, slightly faster onset (30–60 minutes).
• Vapocoolant sprays (e.g., ethyl chloride, Pain Ease): Applied seconds before needle insertion. Rapid cooling causes transient numbness. Less effective than EMLA but works without pre-application planning. Works best for the skin puncture — does not help with deeper tissue.
• Iontophoresis (delivery of lidocaine via mild electrical current): Less commonly used in dialysis; requires special equipment.

Local Infiltration Anesthesia

• 1% lidocaine, 0.1–0.2 mL via a 27–30G needle intradermally at the planned insertion site
• Virtually eliminates insertion pain
• The problem: The lidocaine injection itself hurts (though far less than an unblocked fistula needle)
• Buffering trick: Adding sodium bicarbonate (1:10 dilution) to lidocaine raises pH, dramatically reducing the burning sensation of injection
• Most effective approach after EMLA for the most pain-sensitive patients

Needle Technique for Comfort

• Angle matters: Too steep an angle increases the length of needle in tissue before entering the vein
• Sharp needles: A fresh, sharp needle causes less pain than a dull one. Inspect needle tip — any visible burr means discard it
• Temperature: Room-temperature needles are better tolerated than cold ones
• Speed of insertion: A confident, smooth motion is less painful than hesitation
• Distraction techniques: Talking to the patient, having them look away, controlled breathing

Buttonhole for Pain Reduction

---

10.3 Arm Positioning and Preparation

• Warm compress or warm soak of the fistula arm for 5–10 minutes before cannulation:
  • Vasodilation of the fistula → more prominent, easier to see and feel
  • Reduced vascular spasm during cannulation
  • Reduced patient discomfort
  • Particularly helpful in winter or cold environments
• Arm elevation for patients with edema (oedema compresses the fistula)
• Fist clenching: Asking the patient to make a fist increases venous distension — useful for the venous needle placement

---

10.4 Psychological Aspects

• Needle phobia is common and understandable — acknowledge it, never dismiss it
• Patient familiarity with their own fistula is valuable — experienced patients often know exactly where the best spots are, what angle works, whether they feel better with slow or fast insertion
• Self-cannulation programs (particularly using the buttonhole technique) give patients agency and often dramatically improve their quality of life and relationship with dialysis
• Dignity and privacy: Even a routine procedure deserves care and respect — rushing cannulation, performing it without explanation, or dismissing patient feedback about pain is unacceptable practice

---

PART 11 — FISTULA NEEDLE CONSTITUENTS AND COMPOSITION

11.1 What Is the Needle Made Of?

The Cannula (Shaft):

• Material: Medical-grade stainless steel (type 304 or 316L) — chosen for:
  • Strength at thin gauge
  • Resistance to corrosion from blood
  • Biocompatibility
  • Ability to maintain a sharp, clean bevel
• Surface: Electropolished for smoothness, reducing friction during insertion and reducing thrombogenicity
• Gauge: As discussed — 14G, 15G, 16G, 17G depending on use case
• Length: Typically 25 mm (1 inch) for standard cannulation; 35 mm for deep fistulas

The Hub:

• Material: Medical-grade ABS plastic or polycarbonate
• Contains the Luer-lock or slip-fit connection to the blood line
• Color-coded by convention:
  • Red hub/clamp: Arterial needle (blood out)
  • Blue hub/clamp: Venous needle (blood return)
  • This color coding is universal and critical — connecting the wrong needle to the wrong line reverses blood flow direction, dramatically increasing recirculation

The Wings:

• Material: Soft PVC (polyvinyl chloride) or silicone
• Must be pliable enough to conform to the curved arm surface for secure taping
• Some designs have ridged grip surfaces for better control during insertion

The Tubing:

• Material: Medical-grade PVC plasticized with DEHP (di(2-ethylhexyl) phthalate) — note: some centers now use DEHP-free tubing due to concerns about phthalate exposure in long-term dialysis patients
• Length: 15–30 cm
• Contains a roller clamp for flow control

The Inner Lumen Coating:

• Some needles have a heparin coating on the inner lumen to reduce micro-clotting during the period between priming and connection
• Some are pre-filled with normal saline or heparinized saline at the factory

---

11.2 The Blood Lines (Part A and Part B Tubing Sets)

Arterial Blood Line (Part A):

• PVC tubing, DEHP or DEHP-free
• Contains a pump segment — a thicker-walled segment of tubing that sits within the peristaltic blood pump. The pump compresses and releases this segment in a rolling motion to push blood forward. This segment is made of a special grade of PVC that can withstand millions of compression cycles without cracking.
• Has a pre-pump sampling port (usually a Luer port) for drawing blood samples
• Has a heparin injection port post-pump for anticoagulant delivery

Venous Blood Line (Part B):

• Contains the drip chamber — an expanded segment where blood flow slows, allowing air bubbles to rise and be detected. Usually 30–50 mL volume.
• The drip chamber has a vent and an air detection port for the machine's ultrasonic air sensor
• Contains a post-dialyzer sampling port
• Has a venous pressure monitoring port — connects to the machine's transducer via a filter/line

Line Materials and Patient Safety:

• All blood-contacting surfaces are tested for pyrogen-free status, cytotoxicity, and hemolysis
• Gamma-irradiated for sterility (most common)
• Single-use — reuse of blood tubing is prohibited in most countries (though historically practiced in resource-limited settings with specific reprocessing protocols)

---

11.3 How Much of the Blood Is Outside the Body?

• Adult average blood volume: 4,500–5,500 mL
• ECV represents 5–7% of total blood volume in an average adult
• In a 45 kg patient with small blood volume (~3,500 mL): ECV represents nearly 8–10% — significant hemodynamic stress, especially if the patient is already anemic or hypotensive
• Pediatric patients on dialysis are at the highest risk — blood priming of the circuit is required in small children (using donor blood or the patient's own blood to fill the circuit rather than saline, to avoid acute hemodilution)

---

PART 12 — ADVANCED TOPICS AND MONITORING

12.1 Fistula Surveillance and Monitoring

Monitoring (Detecting problems early):

• Monthly clinical assessment of thrill, bruit, access flow adequacy
• Static venous pressure ratio (SVP/MAP) — if the VP at a standardized low BFR divided by mean arterial pressure is elevated (> 0.4–0.5), suspect downstream stenosis
• Kt/V trending — if a patient's Kt/V drops without explanation (same BFR, time, dialyzer), suspect access problem, recirculation, or clot

Surveillance (Proactive imaging):

• Duplex Doppler ultrasound: Measures access flow volume (mL/min). Flow < 500–600 mL/min in a fistula suggests stenosis. Declining trend is more important than any single value.
• Dilution methods (e.g., Transonic HD01, Crit-Line): During dialysis, saline is injected and a sensor detects dilution in the venous line — calculates access flow and recirculation in real time
• Per KDOQI guidelines: any fistula with access flow < 500 mL/min or declining by > 25% over 4 months should be referred for fistulogram

---

12.2 Recirculation Measurement

1. Stop dialysis briefly
2. Draw blood simultaneously from the arterial needle (reflecting access flow), venous needle, and a peripheral vein
3. Calculate: Recirculation (%) = [(peripheral urea − arterial needle urea) / (peripheral urea − venous needle urea)] × 100

4. 10% is significant; > 20% requires investigation

---

12.3 Heparin and Anticoagulation in the Circuit

---

12.4 Online Hemodiafiltration (OL-HDF) — The Advanced Frontier

• Very high BFR (350–450 mL/min) — because you need high blood delivery for high convection volumes
• Very high DFR (600–800 mL/min) — to generate enough ultra-pure dialysate to use as infusion fluid
• Ultra-pure dialysate (endotoxin-free, sterile standard) — because it is infused directly into the blood
• High-flux dialyzer with large pores

---

12.5 Common Complications During Cannulation and Dialysis

---

12.6 Documentation — What Must Be Recorded Every Session

• Needle gauge used (arterial and venous)
• Needle sites (description or diagram — which segment of the fistula, distance from landmarks)
• Needle direction (antegrade/retrograde for each)
• Number of attempts (one-attempt success rate is a quality metric)
• Any complications during cannulation
• Initial AP and VP at start BFR
• BFR achieved (actual, not just prescribed)
• DFR prescribed
• Heparin dose
• Time treatment started and ended
• Any alarms or interruptions
• Post-dialysis AP/VP
• Needle removal and hemostasis time

---

PART 13 — QUICK REFERENCE SUMMARIES

13.1 Cannulation Direction Quick Reference

13.2 BFR and DFR Optimization Summary

• Below BFR 300: Unlikely to achieve adequate Kt/V in a standard 4-hour session without extended time
• BFR 300 + DFR 500 = minimum standard prescription for most patients
• BFR 350–400 + DFR 500–600 = optimal prescription for well-established fistulas
• DFR above 500 mL/min provides meaningful benefit only when BFR ≥ 350 mL/min
• Never prescribe DFR < BFR — that is almost always suboptimal

13.3 New Fistula Cannulation Checklist

• Rule of 6s confirmed (diameter, depth, length, time)
• Surgeon clearance obtained
• Most experienced cannulator assigned
• Start with 17G needle
• BFR ≤ 220 mL/min first session
• One-attempt-only policy
• Document sites meticulously for every session
• Decide rope ladder vs. buttonhole track from Day 1
• Patient education about access care completed

---